{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Healthcare+Provider+dosing&page=2", "query": { "intervention": "Healthcare Provider dosing", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Healthcare+Provider+dosing&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-28T10:25:26.058Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05415891", "title": "The IMPROV Project: Improving Mental Health and Substance Use Treatment Provision (IMPROV) Among People Living With HIV (Human Immunodeficiency Virus) in Atlanta", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Mental Health Disorder", "Substance Use Disorder", "Stigmatization", "Implementation Science" ], "interventions": [ { "name": "Modified Health Policy Project (HPP) HIV-Stigma and Discrimination Reduction Training Curriculum", "type": "BEHAVIORAL" }, { "name": "You℞ Decision prescribing platform", "type": "DEVICE" } ], "intervention_types": [ "BEHAVIORAL", "DEVICE" ], "sponsor": "RTI International", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 333, "start_date": "2022-06", "completion_date": "2023-06", "has_results": false, "last_update_posted_date": "2022-06-13", "last_synced_at": "2026-09-28T10:25:26.058Z", "location_count": 2, "location_summary": "Decatur, Georgia • Duluth, Georgia", "locations": [ { "city": "Decatur", "state": "Georgia" }, { "city": "Duluth", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05415891" }, { "nct_id": "NCT04584528", "title": "Implementing an Individualized Pain Plan (IPP) for ED Treatment of VOE's in Sickle Cell Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Sickle Cell Disease", "Genetic Disease", "Hematologic Diseases", "Anemia, Sickle Cell" ], "interventions": [ { "name": "Electronic Health Record (EHR) Embedded Individualized Pain Plan (IPP)", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 279, "start_date": "2020-10-27", "completion_date": "2022-10-01", "has_results": false, "last_update_posted_date": "2022-10-28", "last_synced_at": "2026-09-28T10:25:26.058Z", "location_count": 8, "location_summary": "Oakland, California • Augusta, Georgia • Chicago, Illinois + 5 more", "locations": [ { "city": "Oakland", "state": "California" }, { "city": "Augusta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "St Louis", "state": "Missouri" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04584528" }, { "nct_id": "NCT07611786", "title": "Development of Healthcare Transition for Patients With Congenital Adrenal Hyperplasia", "overall_status": "NOT_YET_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Congenital Adrenal Hyperplasia" ], "interventions": [ { "name": "exposure to healthcare transition protocol", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "16 Years", "maximum_age": null, "sex": "ALL", "summary": "16 Years and older" }, "enrollment_count": 40, "start_date": "2026-10", "completion_date": "2029-10", "has_results": false, "last_update_posted_date": "2026-08-21", "last_synced_at": "2026-09-28T10:25:26.058Z", "location_count": 1, "location_summary": "Birmingham, Alabama", "locations": [ { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT07611786" }, { "nct_id": "NCT07842341", "title": "MH-Rx Study (Baby on Board: Check-in on You, Your Medication, & Your Blood Pressure)", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hypertensive Disorders of Pregnancy", "Chronic Hypertension in Pregnancy", "Gestational Hypertension" ], "interventions": [ { "name": "Community Health Worker (CHW)/Social Worker (SW)-led non-medical health related needs (NMHRN) intervention + Clinician-Led Medication Therapy Management (MTM) with remote blood pressure monitoring", "type": "BEHAVIORAL" }, { "name": "Active Comparator (Control group)", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Texas Southern University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "FEMALE", "summary": "18 Years to 45 Years · Female only" }, "enrollment_count": 158, "start_date": "2026-09-09", "completion_date": "2029-12-30", "has_results": false, "last_update_posted_date": "2026-09-25", "last_synced_at": "2026-09-28T10:25:26.058Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07842341" }, { "nct_id": "NCT04803786", "title": "A Patient-Centric, Prospective, Observational, Non-Interventional Switch Study of XYWAV in Narcolepsy", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Narcolepsy" ], "interventions": [ { "name": "Transition from Xyrem to Xywav", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Jazz Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 110, "start_date": "2021-04-09", "completion_date": "2022-02-24", "has_results": false, "last_update_posted_date": "2022-06-30", "last_synced_at": "2026-09-28T10:25:26.058Z", "location_count": 1, "location_summary": "Palo Alto, California", "locations": [ { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04803786" }, { "nct_id": "NCT03908762", "title": "mHealth Titration and Management", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diabetes Mellitus, Type 2", "Diabetic Complication" ], "interventions": [ { "name": "iSage App with connected glucometer", "type": "DEVICE" }, { "name": "Magnet", "type": "BEHAVIORAL" } ], "intervention_types": [ "DEVICE", "BEHAVIORAL" ], "sponsor": "Amalgam Rx, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "21 Years to 100 Years" }, "enrollment_count": 40, "start_date": "2019-01-01", "completion_date": "2020-03", "has_results": false, "last_update_posted_date": "2019-04-09", "last_synced_at": "2026-09-28T10:25:26.058Z", "location_count": 1, "location_summary": "Kansas City, Kansas", "locations": [ { "city": "Kansas City", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03908762" }, { "nct_id": "NCT04363450", "title": "Hydroxychloroquine as Prophylaxis for COVID-19 in Healthcare Workers (HCQPreP)", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "COVID-19", "Corona Virus Infection", "Wuhan Coronavirus", "Prophylaxis", "Healthcare Worker", "Sars-CoV2", "Hydroxychloroquine" ], "interventions": [ { "name": "Hydroxychloroquine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Louisiana State University Health Sciences Center in New Orleans", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1700, "start_date": "2020-04-27", "completion_date": "2021-06-01", "has_results": false, "last_update_posted_date": "2020-09-02", "last_synced_at": "2026-09-28T10:25:26.058Z", "location_count": 2, "location_summary": "Lafayette, Louisiana", "locations": [ { "city": "Lafayette", "state": "Louisiana" }, { "city": "Lafayette", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT04363450" }, { "nct_id": "NCT07521371", "title": "Intranasal Insulin for Autism Spectrum Disorder in Children and Young Adults Aged 4 to 21 Years", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Autism Spectrum Disorder", "Autism Spectrum Disorder (ASD)", "Autism Spectrum Disorder High-Functioning", "Autism Spectrum Disorder With Absence of Functional Language", "Autism Spectrum Disorder With Impaired Functional Language", "Autistic Disorder of Childhood Onset With Full Syndrome", "Autistic Disorders Spectrum", "Autistic Disorder", "Autistic Disorder in Children and Adolescents", "Neurodevelopmental Disorders", "Neurodevelopmental Disorders (NDD)", "Neurodevelopmental Disorders and Developmental Abnormalities" ], "interventions": [], "intervention_types": [], "sponsor": "Healing Hope International", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "21 Years", "sex": "ALL", "summary": "4 Years to 21 Years" }, "enrollment_count": 12, "start_date": "2026-06-01", "completion_date": "2030-01-30", "has_results": false, "last_update_posted_date": "2026-04-09", "last_synced_at": "2026-09-28T10:25:26.058Z", "location_count": 1, "location_summary": "Spring, Texas", "locations": [ { "city": "Spring", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07521371" }, { "nct_id": "NCT07806838", "title": "Effects of Dietary Supplements on Muscle Mass and Function While Using GLP-1 Medication", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Obesity & Overweight", "Muscle Mass and Strength", "Muscle Function" ], "interventions": [ { "name": "Whey Protein Supplementation", "type": "DIETARY_SUPPLEMENT" }, { "name": "Maltodextrin Placebo Capsules", "type": "DIETARY_SUPPLEMENT" }, { "name": "Mixed Spice Capsules", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "University of California, Los Angeles", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 75, "start_date": "2026-09-10", "completion_date": "2028-09-01", "has_results": false, "last_update_posted_date": "2026-09-08", "last_synced_at": "2026-09-28T10:25:26.058Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07806838" }, { "nct_id": "NCT07730112", "title": "Adapting a Psychosocial Support Intervention for the Rett Syndrome Community", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Rett Syndrome", "Family Caregivers", "Social Support", "Psychological Support" ], "interventions": [ { "name": "Those who have patients prescribed Daybue", "type": "OTHER" }, { "name": "Caregiver Speaks + Daybue", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Colorado State University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 60, "start_date": "2026-08-01", "completion_date": "2028-05-31", "has_results": false, "last_update_posted_date": "2026-07-28", "last_synced_at": "2026-09-28T10:25:26.058Z", "location_count": 1, "location_summary": "Fort Collins, Colorado", "locations": [ { "city": "Fort Collins", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT07730112" } ] }